WallStreetZenWallStreetZen

NASDAQ: VTGN
Vistagen Therapeutics Inc Stock Ownership - Who owns Vistagen Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vistagen Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joshua S. PrinceChief Operating Officer2025-12-314,386$0.56
$2.47kBuy
Reid G. AdlerChief Legal Officer2025-06-307,541$1.70
$12.82kBuy
Cynthia Lynn AndersonCHIEF FINANCIAL OFFICER2025-06-306,617$1.70
$11.25kBuy
Joshua S. PrinceChief Operating Officer2025-06-304,882$1.70
$8.30kBuy
Shawn SinghPresident and CEO2025-06-307,541$1.70
$12.82kBuy

1 of 1

VTGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTGN insiders and whales buy or sell their stock.

VTGN Shareholders

What type of owners hold Vistagen Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Venrock Healthcare Capital Partners II LP52.09%20,637,286$11.54MInsider
Holding Co Cato8.36%3,310,836$1.85MInsider
Orbimed Advisors LLC7.72%3,060,000$1.71MInstitution
Tcg Crossover Management LLC6.76%2,676,580$1.50MInstitution
Vanguard Group Inc4.61%1,824,738$1.02MInstitution
Platinum Long Term Growth VII LLC3.93%1,558,862$871.40kInsider
Commodore Capital LP2.02%799,244$446.78kInsider
Adar1 Capital Management LLC1.57%623,575$348.58kInstitution
Stempoint Capital LP1.56%616,749$344.76kInstitution
Jane Street Group LLC1.33%527,127$294.66kInstitution

1 of 3

VTGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTGN33.04%66.96%Net BuyingNet Buying
NRSN1.41%0.00%
NNVC5.60%94.40%
APLM0.40%0.00%
LONA33.15%66.85%Net BuyingNet Buying
View Top Biotech Stocks

Vistagen Therapeutics Stock Ownership FAQ

Who owns Vistagen Therapeutics?

Vistagen Therapeutics (NASDAQ: VTGN) is owned by 34.46% institutional shareholders, 69.84% Vistagen Therapeutics insiders, and 0.00% retail investors. Venrock Healthcare Capital Partners II LP is the largest individual Vistagen Therapeutics shareholder, owning 20.64M shares representing 52.09% of the company. Venrock Healthcare Capital Partners II LP's Vistagen Therapeutics shares are currently valued at $11.54M.

If you're new to stock investing, here's how to buy Vistagen Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.